Cognition Therapeutics, Inc. (CGTX) DCF Valuation

Cognition Therapeutics, Inc. (CGTX) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Cognition Therapeutics, Inc. (CGTX) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Enhance your investment choices with the Cognition Therapeutics, Inc. (CGTX) DCF Calculator! Explore real financial data for Cognition Therapeutics, adjust growth projections and expenses, and instantly observe how modifications affect the intrinsic value of CGTX.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -3.5 -6.0 -13.4 -21.1 -25.5 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .1 .1 .1 .2 .3 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -3.6 -6.1 -13.5 -21.4 -25.8 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 2.9 5.2 54.7 41.6 29.9 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 4.1 1.2 2.3 3.7 1.3
Account Receivables, % 100 100 100 100 100
Inventories .1 .5 2.0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable 2.4 2.0 4.2 3.2 3.7 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure -.1 .0 .0 -.2 -.1 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -5.1 -7.8 -11.8 .8 -25.8 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -7.1 -5.5 -12.2 .5 -22.8 -2.4 .0 .0 .0 .0
WACC, % 10.46 10.46 10.43 10.25 10.46 10.41 10.41 10.41 10.41 10.41
PV UFCF
SUM PV UFCF -2.2
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -2
Net Debt -29
Equity Value 26
Diluted Shares Outstanding, MM 30
Equity Value Per Share 0.88

What You Will Receive

  • Flexible Forecast Inputs: Modify key assumptions (growth %, margins, WACC) to explore various scenarios.
  • Industry-Specific Data: Cognition Therapeutics, Inc.'s (CGTX) financial information pre-loaded to facilitate your analysis.
  • Instant DCF Results: The template automatically computes Net Present Value (NPV) and intrinsic value.
  • Tailored and Professional: A sleek Excel model that can be customized to fit your valuation requirements.
  • Designed for Analysts and Investors: Perfect for assessing projections, validating strategies, and enhancing efficiency.

Key Features

  • Comprehensive Clinical Data: Access reliable pre-loaded historical performance metrics and future outlooks.
  • Adjustable Research Parameters: Modify highlighted fields such as R&D expenses, market penetration rates, and profit margins.
  • Real-Time Analytics: Automatic recalculations for discounted cash flow (DCF), Net Present Value (NPV), and revenue forecasts.
  • Interactive Dashboard: Intuitive charts and summaries to help visualize your investment analysis.
  • Suitable for All Skill Levels: A user-friendly format designed for investors, analysts, and industry professionals.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review pre-entered Cognition Therapeutics data (historical and projected).
  3. Step 3: Adjust key assumptions (yellow cells) based on your analysis.
  4. Step 4: View automatic recalculations for Cognition Therapeutics’ intrinsic value.
  5. Step 5: Use the outputs for investment decisions or reporting.

Why Choose This Calculator for Cognition Therapeutics, Inc. (CGTX)?

  • User-Friendly Interface: Tailored for both novices and seasoned professionals.
  • Customizable Variables: Easily adjust parameters to suit your financial analysis.
  • Real-Time Feedback: Monitor immediate updates to Cognition Therapeutics’ valuation with every input change.
  • Pre-Loaded Data: Comes with Cognition Therapeutics’ actual financial figures for swift evaluations.
  • Endorsed by Experts: Utilized by investors and analysts for making well-informed choices.

Who Should Use This Product?

  • Investors: Evaluate Cognition Therapeutics' (CGTX) market position before making investment decisions.
  • CFOs and Financial Analysts: Optimize valuation methodologies and assess financial forecasts for CGTX.
  • Startup Founders: Understand the valuation strategies of biotechnology companies like Cognition Therapeutics.
  • Consultants: Create comprehensive valuation reports for clients in the biopharmaceutical sector.
  • Students and Educators: Utilize current data to learn and teach valuation principles in healthcare innovation.

What the Template Contains

  • Comprehensive DCF Model: Editable template featuring in-depth valuation calculations.
  • Real-World Data: Cognition Therapeutics, Inc. (CGTX)’s historical and projected financials preloaded for analysis.
  • Customizable Parameters: Modify WACC, growth rates, and tax assumptions to explore various scenarios.
  • Financial Statements: Complete annual and quarterly breakdowns for enhanced insights.
  • Key Ratios: Integrated analysis for profitability, efficiency, and leverage metrics.
  • Dashboard with Visual Outputs: Charts and tables designed for clear, actionable results.

No products were found matching.